ARTICLE | Company News
Novartis receives EU approval
March 30, 2001 8:00 AM UTC
Novartis (NVS; SWX:NOVN) received EU marketing approval for Zometa zeledronic acid, an intravenous bisphosphonate, to treat tumor-induced hypercalcemia of malignancy. Zometa has marketing clearance in...